You are here
,

Takeda sells dry eye drug to Novartis to help cut debt

  • Thursday, 9 May 2019
  • Posted by Aftab Ahmad
  • 0 Comments
Takeda Pharmaceutical Co Ltd agreed to sell its dry eye drug to Swiss drugmaker Novartis AG for $3.4 billion and potential milestone payments of up to $1.9 billion, in the first divestment since its takeover of Britain's Shire.


from Reuters: Health News https://reut.rs/2Vciu0S

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply